327 related articles for article (PubMed ID: 29153587)
21. Validation of Plasmodium vivax centromere and promoter activities using Plasmodium yoelii.
Thawnashom K; Kaneko M; Xangsayarath P; Chaiyawong N; Yahata K; Asada M; Adams JH; Kaneko O
PLoS One; 2019; 14(12):e0226884. PubMed ID: 31860644
[TBL] [Abstract][Full Text] [Related]
22. Uncovering the transmission dynamics of Plasmodium vivax using population genetics.
Barry AE; Waltmann A; Koepfli C; Barnadas C; Mueller I
Pathog Glob Health; 2015 May; 109(3):142-52. PubMed ID: 25891915
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Global Research on Malaria and
Garrido-Cardenas JA; Cebrián-Carmona J; González-Cerón L; Manzano-Agugliaro F; Mesa-Valle C
Int J Environ Res Public Health; 2019 May; 16(11):. PubMed ID: 31159165
[No Abstract] [Full Text] [Related]
24. Epidemiology and Control of Plasmodium vivax in Afghanistan.
Leslie T; Nahzat S; Sediqi W
Am J Trop Med Hyg; 2016 Dec; 95(6 Suppl):72-77. PubMed ID: 27708189
[TBL] [Abstract][Full Text] [Related]
25. Plasmodium vivax Controlled Human Malaria Infection - Progress and Prospects.
Payne RO; Griffin PM; McCarthy JS; Draper SJ
Trends Parasitol; 2017 Feb; 33(2):141-150. PubMed ID: 27956060
[TBL] [Abstract][Full Text] [Related]
26. Defining the relationship between Plasmodium vivax parasite rate and clinical disease.
Battle KE; Cameron E; Guerra CA; Golding N; Duda KA; Howes RE; Elyazar IR; Price RN; Baird JK; Reiner RC; Smith DL; Gething PW; Hay SI
Malar J; 2015 May; 14():191. PubMed ID: 25948111
[TBL] [Abstract][Full Text] [Related]
27. Impact of enhanced malaria control on the competition between Plasmodium falciparum and Plasmodium vivax in India.
Prosper O; Martcheva M
Math Biosci; 2013 Mar; 242(1):33-50. PubMed ID: 23261665
[TBL] [Abstract][Full Text] [Related]
28. Infection of laboratory colonies of Anopheles mosquitoes with Plasmodium vivax from cryopreserved clinical isolates.
Shaw-Saliba K; Clarke D; Santos JM; Menezes MJ; Lim C; Mascarenhas A; Chery L; Gomes E; March S; Bhatia SN; Rathod PK; Ferreira MU; Catteruccia F; Duraisingh MT
Int J Parasitol; 2016 Oct; 46(11):679-83. PubMed ID: 27456552
[TBL] [Abstract][Full Text] [Related]
29. A model of Plasmodium vivax concealment based on Plasmodium cynomolgi infections in Macaca mulatta.
Fonseca LL; Joyner CJ; ; Galinski MR; Voit EO
Malar J; 2017 Sep; 16(1):375. PubMed ID: 28923058
[TBL] [Abstract][Full Text] [Related]
30. Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia.
Golassa L; White MT
Malar J; 2017 Jul; 16(1):301. PubMed ID: 28750669
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax.
Sattabongkot J; Yimamnuaychoke N; Leelaudomlipi S; Rasameesoraj M; Jenwithisuk R; Coleman RE; Udomsangpetch R; Cui L; Brewer TG
Am J Trop Med Hyg; 2006 May; 74(5):708-15. PubMed ID: 16687667
[TBL] [Abstract][Full Text] [Related]
32. Proteomics of Plasmodium vivax malaria: new insights, progress and potential.
Venkatesh A; Patel SK; Ray S; Shastri J; Chatterjee G; Kochar SK; Patankar S; Srivastava S
Expert Rev Proteomics; 2016 Aug; 13(8):771-82. PubMed ID: 27389635
[TBL] [Abstract][Full Text] [Related]
33. An update on the search for a Plasmodium vivax vaccine.
Herrera S; Corradin G; Arévalo-Herrera M
Trends Parasitol; 2007 Mar; 23(3):122-8. PubMed ID: 17258937
[TBL] [Abstract][Full Text] [Related]
34. Identification of different malaria patterns due to Plasmodium falciparum and Plasmodium vivax in Ethiopian children: a prospective cohort study.
Seyoum D; Kifle YG; Rondeau V; Yewhalaw D; Duchateau L; Rosas-Aguirre A; Speybroeck N
Malar J; 2016 Apr; 15():208. PubMed ID: 27075667
[TBL] [Abstract][Full Text] [Related]
35. Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia.
Tripura R; Peto TJ; Veugen CC; Nguon C; Davoeung C; James N; Dhorda M; Maude RJ; Duanguppama J; Patumrat K; Imwong M; von Seidlein L; Grobusch MP; White NJ; Dondorp AM
Malar J; 2017 Jan; 16(1):56. PubMed ID: 28143518
[TBL] [Abstract][Full Text] [Related]
36. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
[TBL] [Abstract][Full Text] [Related]
37. Advancing Key Gaps in the Knowledge of
Aparici Herraiz I; Caires HR; Castillo-Fernández Ó; Sima N; Méndez-Mora L; Risueño RM; Sattabongkot J; Roobsoong W; Hernández-Machado A; Fernandez-Becerra C; Barrias CC; Del Portillo HA
Front Cell Infect Microbiol; 2022; 12():920204. PubMed ID: 35873153
[No Abstract] [Full Text] [Related]
38. Are insecticide-treated bednets more protective against Plasmodium falciparum than Plasmodium vivax-infected mosquitoes?
Bockarie MJ; Dagoro H
Malar J; 2006 Feb; 5():15. PubMed ID: 16504027
[TBL] [Abstract][Full Text] [Related]
39. [Is Plasmodium vivax still a paradigm for uncomplicated malaria?].
Picot S
Med Mal Infect; 2006 Aug; 36(8):406-13. PubMed ID: 16842954
[TBL] [Abstract][Full Text] [Related]
40. Plasmodium vivax in Hematopoietic Niches: Hidden and Dangerous.
Silva-Filho JL; Lacerda MVG; Recker M; Wassmer SC; Marti M; Costa FTM
Trends Parasitol; 2020 May; 36(5):447-458. PubMed ID: 32298632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
